NewsRoom Articles - Page 94 of 207

WednesdaySep 07, 2022 11:15 am

Odyssey Health, Inc. (ODYY) Receives Approval to Proceed with Cohort II of Its Phase I Trial’s Multiday Ascending Dosing Stage

Medical company Odyssey Health has received approval from the Safety Review Committee to start Cohort II of its Phase I trial’s Multiday Ascending Dosing (“MAD”) stage The approval follows evidence that Odyssey’s PRV-002 concussion drug candidate was safe and well-tolerated, as seen in Cohort I of the MAD stage The pharmacokinetic analysis also supports the hypothesis that more drug is getting to the brain itself, backing the company’s use of its patent-pending breath-propelled intranasal drug administration device The company believes that the intranasal drug/delivery combination will be instrumental in the success of the PRV-002 drug candidate in planned Phase II/III…

WednesdaySep 07, 2022 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Posts Slight Q2 2022 Performance Improvement; Maintains Priorities and Focus on Advancing its Clinical Development Program for Berubicin

CNS reported a decrease in losses from $3.8 million in Q2 2021 to $3.6 million in Q2 2022, as well as a drop in research and development expenses from $2.7 million to $2.2 million, with an increase in general and administrative expenses from $1.1 million to $1.3 million The company closed the quarter with $9.0 million in cash, and a working capital of approximately $10.3 million which, it is confident, will fund its operations into the 2023 calendar year CNS looks to continue site initiations across the U.S., Italy, France, Spain, and Switzerland, while also pushing for regulatory and ethics…

WednesdaySep 07, 2022 9:44 am

Accessibility Issues Prevent Individuals in Rural Areas from Undergoing Lifesaving Tumor Treatment

Tumors remain one of the deadliest diseases in the world, accounting for around one in six deaths globally in 2020. While scientists may not have found a cure for life-threatening tumors despite decades of research, there are a variety of treatments that can reduce and even eliminate tumors. However, people who live in rural areas have limited access to cancer treatments that could save their lives, highlighting a startling inequality in access to lifesaving cancer treatments. For starters, some cancer patients have had their tumors completely eradicated after undergoing Chimeric antigen receptor T-cell (CAR T-cell) therapy. However, patients who reside…

TuesdaySep 06, 2022 11:22 am

Research Indicates Better Sleep Efficiency Benefits Fibromyalgia Sufferers

New research has found that improved sleep efficiency in patients who suffer from fibromyalgia and insomnia may improve their pain-related disorder. Fibromyalgia is a condition characterized by extensive musculoskeletal pain and tenderness, which is often accompanied by fatigue, mood and memory as well as sleep issues. The disorder is often caused by stressful events, which may include emotional, psychological or physical stress. Injuries or viral infections may also cause this pain disorder. On the other hand, insomnia is a sleep disorder that makes it hard for individuals to fall asleep or stay asleep. This common disorder may also cause individuals…

FridaySep 02, 2022 10:09 am

Study Highlights Need for Postnatal Depression Screening

Researchers at the University of Queensland have highlighted the need to screen for perinatal depression for women during the pregnancy period, after learning that women suffering from persistent depression have a heightened risk of developing the condition. Perinatal depression includes symptoms of depression, stress and anxiety that women sometimes experience from conception to a year following infant birth. The study’s objective was to assess the prevalence, timing of onset and duration of depression symptoms in the perinatal period in women with depression. The study involved more than 7,000 participants who were divided into two subgroups: women who had previously been…

ThursdaySep 01, 2022 10:58 am

Research Suggests Some 50% of Cancers Result from Preventable Factors

Cancer is said to be the second-leading cause of death globally, following heart disease. Among the different types of cancer, lung cancer is the leading cause of cancer death, followed by colorectal and liver cancers. A new study suggests that roughly 44% of the deaths caused by cancer can be attributed to risk factors that are preventable. These factors include drinking too much alcohol, smoking and having a high BMI. The researchers were focused on analyzing the relationship between cancer and various risk factors, using data obtained from the Global Burden of Disease project by the Institute for Health Metrics…

ThursdaySep 01, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), Moving the Needle in GBM and Brain Cancer Research

When CNS went public in 2019, the funds went primarily into pre-clinical preparation, trial design approval, and drug manufacturing for its potentially pivotal global clinical trial of Berubicin for recurrent glioblastoma multiforme (“GBM”) So far, CNS has received FDA Fast Track Designation on its Berubicin clinical study, inching the company closer to offering a viable solution to the millions of people dealing with GBM, a devastating malignant brain cancer It remains committed to pushing the envelope in terms of research and development of potential GBM treatment, as we ll as brain cancers in general, to offer a viable solution to…

WednesdayAug 31, 2022 12:47 pm

Ways to Prevent a Child from Choking

Children are prone to various accidents that can occur anywhere and at any time. Among the most common of these accidents is choking, which occurs when a child’s airway is obstructed. Unlike an adult’s airway, a child’s airway is smaller, which means it can easily be blocked. Figures show that an estimated 40 children are admitted to emergency rooms for choking, with one child losing their life by choking on food every five days in America. Below, we look at various choking hazards you should be aware of and what foods you can avoid as well as how to prevent…

WednesdayAug 31, 2022 11:30 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Pioneering Efforts as Studies, Research Show Psilocybin’s Potential in Treating AUD

A new study shows promise in treating alcohol addiction with psychedelic mushroom compound, psilocybin These results align with efforts and expectations of Cybin, a leading ethical biopharmaceutical company championing psilocybin After receiving FDA approval, the company is moving forward with a first-in-human clinical trial evaluating CYB003 A new study published in JAMA Psychiatry offers hope for those struggling with alcoholism (https://ibn.fm/jV5o9), showing promise in treating alcohol addiction with the psychedelic compound psilocybin. This news aligns with initiatives of Cybin (NEO: CYBN) (NYSE American: CYBN), a leading ethical biopharmaceutical company, which has a drug in development, CYB003, for the treatment of alcohol…

TuesdayAug 30, 2022 11:44 am

Study Finds Children Have Better Outcomes with Kidney Transplants from Living Donors

A new study has found that pediatric patients who undergo kidney transplants may have better outcomes if the donated kidney comes from a biologically unrelated and living donor in comparison to a deceased donor. For their research, the scientists reviewed data obtained from the Organ Procurement and Transplantation Network database during the period between January 2001 and September 2021. The investigators examined more than 12,000 children who had received kidney transplants during the study period. Of the total number of children, 61% received kidneys from deceased donors, 36% received kidneys from living related donors and less than 3% received kidneys…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Odyssey Health, Inc. (ODYY) Receives Approval to Proceed with Cohort II of Its Phase I Trial’s Multiday Ascending Dosing Stage

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Posts Slight Q2 2022 Performance Improvement; Maintains Priorities and Focus on Advancing its Clinical Development Program for Berubicin

Accessibility Issues Prevent Individuals in Rural Areas from Undergoing Lifesaving Tumor Treatment

Research Indicates Better Sleep Efficiency Benefits Fibromyalgia Sufferers

Study Highlights Need for Postnatal Depression Screening

Research Suggests Some 50% of Cancers Result from Preventable Factors

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), Moving the Needle in GBM and Brain Cancer Research

Ways to Prevent a Child from Choking

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Pioneering Efforts as Studies, Research Show Psilocybin’s Potential in Treating AUD

Study Finds Children Have Better Outcomes with Kidney Transplants from Living Donors

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search